Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Hematopoietic Stem Cell Transplantation and Lymphodepletion for the Treatment of Cancer Publisher



Barr KM1 ; Khoshbin AP2, 3 ; Gershan JA4 ; Johnson BD5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Milwaukee Area Technical College, Milwaukee, WI, United States
  2. 2. Universal Scientific Education and Research Network (USERN), Tehran, Iran
  3. 3. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Division of Hematology/Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, United States
  5. 5. Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, United States

Source: Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition Published:2020


Abstract

Hematopoietic stem cell transplantation (HSCT) can be an effective treatment for hematologic malignancies and, more recently, has shown efficacy for the treatment of solid tumors. Myeloablative, reduced-intensity, or non-myeloablative conditioning serves to eliminate or reduce the number of malignant cells, create space in the hematopoietic compartment for the expansion of transplanted hematopoietic cells, and provide a hematopoietic environment that is conducive to the proliferation of antitumor immune cells. Discussed in this chapter are an overview of HSCT, different sources of hematopoietic stem cells (HSC), treatments used to deplete hematopoietic cells and/or induce lymphodepletion, how these treatments are used as preconditioning for autologous and allogeneic HSCT, and how lymphodepletion augments an antitumor immune response during hematopoietic cell reconstitution. © Springer Nature Switzerland AG 2015, 2021. All rights reserved.
Related Docs
View other Related Docs
1. The Effect of Maternal and Infant Factors on Cord Blood Yield, Pediatric Blood and Cancer (2017)
2. Transplantation, Clinical Immunology (2022)
3. Is There a Stronger Graft-Versus-Leukemia Effect Using Hla-Haploidentical Donors Compared With Hla-Identical Siblings?, Leukemia (2016)
4. The Therapeutic Values of Il-7/Il-7R and the Recombinant Derivatives in Glioma: A Narrative Review, Journal of Interferon and Cytokine Research (2023)
5. Evaluation of Motor Neuron Differentiation Potential of Human Umbilical Cord Blood- Derived Mesenchymal Stem Cells, in Vitro, Journal of Chemical Neuroanatomy (2017)
6. Peripheral Blood Versus Bone Marrow Transplant in Patients With Aplastic Anemia, an Unresolved Issue, Bone Marrow Transplantation (2016)
7. Overview and Recent Advances of Regulatory T Cell Therapy in Solid Organ Transplantation, Iranian Journal of Kidney Diseases (2021)
8. Comparable Outcomes of Allogeneic Peripheral Blood Versus Bone Marrow Hematopoietic Stem Cell Transplantation in Major Thalassemia: A Multivariate Long-Term Cohort Analysis, Biology of Blood and Marrow Transplantation (2019)
Experts (# of related papers)
View all Related Experts
Amir Kasaeian (3)
Mohammad Vaezi (2)
Other Related Docs
9. Peripheral Blood Stem Cell Transplantation From Haploidentical and Unrelated Versus Related Donors for Acute Leukemia in Children, Adolescents and Young Adults (Caya): A Competing Risk Analysis, Cellular Therapy and Transplantation (2022)
10. Developing Novel Therapies for Degenerative Cervical Myelopathy [Ao Spine Recode-Dcm Research Priority Number 7]: Opportunities From Restorative Neurobiology, Global Spine Journal (2022)
11. What Is the Outcome in Patients With Acute Leukaemia Who Survive Severe Acute Graft-Versus-Host Disease?, Journal of Internal Medicine (2018)
12. Long-Term Outcomes of Cord Blood Transplantation From an Hla-Identical Sibling for Patients With Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation, Biology of Blood and Marrow Transplantation (2017)
13. Evaluation of Safety and Efficacy of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Pediatric Bronchiolitis Obliterans Syndrome (Bos) After Allogeneic Hematopoietic Stem Cell Transplantation (Allo-Hsct), Stem Cell Research and Therapy (2023)
14. Prolonged Persistence of Chimeric Antigen Receptor (Car) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward, Frontiers in Immunology (2020)
15. Cancer Immunotherapy: Diverse Approaches and Obstacles, Current Pharmaceutical Design (2022)